ESR1 and breast neoplasm: To assess whether the effects of LYO were indeed due to its best-known components, we treated SKBR3 cells with DADS, one of the major organosulfur molecules present in our extract [38] and known to downregulate invasive potential of breast tumor cells with ER+ or triple-negative phenotypes [41,42].